GlassScriptPhysician profile
Zdenko Korunda
NPI 1104876861
$3,894.98
in general payments reported to CMS, 2019-2025
24 companies · $1,548 in 2025
The $1,548 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $81.58 · 2021: $514 · 2022: $289 · 2023: $418 · 2024: $667 · 2025: $1,548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,633.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,153.20 | 2022-2025 | Intracept, General - Pain Management, General - Therapies |
| Abbott Laboratories | $358.99 | 2019-2024 | Proclaim, Eterna |
| Abbvie INC. | $313.08 | 2021-2025 | |
| Painteq LLC | $297.09 | 2021-2024 | Painteq |
| Allergan, INC. | $217.31 | 2019-2022 | |
| Edwards Lifesciences Corporation | $200.18 | 2025 | |
| Vertos Medical, INC. | $192.77 | 2023-2024 | Mild Device Kit |
| Stryker Corporation | $167.01 | 2025 | Mild Device Kit |
| Medtronic, INC. | $165.41 | 2022-2025 | Intellis Adaptivestim |
| Spinal Simplicity, LLC | $151.32 | 2023 | Ha Minuteman G3-R |
| Astrazeneca Pharmaceuticals LP | $121.67 | 2024 | Airsupra |
| Stimwave Technologies Incorporated | $119.11 | 2019 | |
| Axonics, INC. | $114.30 | 2021 | |
| Nevro Corp. | $79.83 | 2019-2024 | Senza |
| Radius Health, INC. | $44.64 | 2021-2024 | Tymlos |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $41.25 | 2021 | |
| Novartis Pharmaceuticals Corporation | $41.00 | 2019-2021 | |
| Medline Industries LP | $26.09 | 2023 | |
| Protega Pharmaceutials INC | $22.14 | 2023 | Roxybond |
| Forte Bio-Pharma LLC | $15.99 | 2019 | |
| Sonex Health, INC. | $14.53 | 2021 | |
| Pfizer INC. | $14.19 | 2019 | |
| Saluda Medical Americas, INC. | $12.19 | 2024 | Evoke |
| Fidia Pharma USA INC. | $11.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zdenko Korunda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.